Skip to main content
KISSEI PHARMACEUTICAL CO.,LTD. logo

KISSEI PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4547 ISIN · JP3240600001 T Manufacturing
Open in API
Filings indexed 72 across all filing types
Latest filing 2025-11-10 Regulatory Filings
Country JP Japan
Listing T 4547

About KISSEI PHARMACEUTICAL CO.,LTD.

https://www.kissei.co.jp/e_contents/

Kissei Pharmaceutical Co., Ltd. is a research-driven company engaged in the discovery, development, manufacturing, and sale of pharmaceutical products. The company concentrates its research and development investments in key therapeutic areas, including urology, renal diseases and dialysis, and rare or intractable diseases. Its broader product portfolio also addresses conditions in metabolic and endocrinological, obstetrics and gynecological, and ophthalmic fields. Committed to creating innovative medicines, Kissei aims to contribute to global health by addressing unmet medical needs. The company also operates in the health foods sector.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. H1 81
2025-11-10 Japanese
半期報告書－第81期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) filed with the Kanto Local Finance Bureau in Japan. It contains comprehensive financial statements, including the '中間連結貸借対照表' (Interim Consolidated Balance Sheet), management analysis of financial conditions, and audit review information. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2025
2025-11-10 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled '臨時報告書' (Extraordinary Report) and explicitly states in Section 1 that it is being submitted based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act because resolutions were made at the '第80期定時株主総会' (80th Annual General Meeting) held on June 24, 2025. Section 2 details the resolutions, including dividend approval, director bonuses, and remuneration changes, along with the voting results (votes for, against, abstentions, and pass/fail status). This structure—reporting the results of a shareholder meeting—is characteristic of a filing related to shareholder voting outcomes. The most specific code for reporting official results from shareholder votes is DVA (Declaration of Voting Results & Voting Rights Announcements). Although it is filed as an Extraordinary Report (which might suggest RNS), the content is purely the voting results of an AGM, making DVA the correct classification.
2025-06-27 Japanese
確認書
Audit Report / Information Classification · 1% confidence The document is extremely short (622 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning '有価証券報告書' (Annual Securities Report, which corresponds to a 10-K equivalent in the US context) and a confirmation statement ('確認書') signed by the CEO and CFO regarding the appropriateness of the contents of the 80th period's Annual Securities Report (covering April 1, 2024, to March 31, 2025). Since this document is a short confirmation/attestation regarding the accuracy of a full annual report, and not the full report itself, it fits best under the general 'Regulatory Filings' category (RNS) or potentially an Audit Report (AR) if it were a formal sign-off, but given the context of confirming the *Annual Securities Report* accuracy, it is a specific regulatory attestation. However, none of the codes perfectly match a 'Confirmation of Annual Report Accuracy' document. Given the structure and content (confirmation of the annual report's appropriateness under the Financial Instruments and Exchange Act), it is a specific regulatory filing. Since '10-K' is for the full report, and this is a confirmation, 'RNS' (Regulatory Filings - fallback) is the most appropriate general category for a specific, short regulatory attestation that isn't a primary report type. FY 2025
2025-06-24 Japanese
内部統制報告書－第80期(2024/04/01－2025/03/31)
Governance Information Classification · 1% confidence The document is titled "内部統制報告書" (Internal Control Report) and explicitly references the legal basis as "金融商品取引法第24条の４の４第１項" (Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act). It details the scope, criteria, and procedures for evaluating internal controls over financial reporting as of the fiscal year-end (March 31, 2025), concluding that the internal controls are effective. This structure and content precisely match the requirements for an Internal Control Report, which is typically filed alongside the Annual Report (10-K) in Japan, but based on the provided definitions, the closest fit for a standalone report detailing internal control assessment is 'Audit Report / Information' (AR), as it deals with assurance/control testing results, although 'Governance Information' (CGR) is also related. However, given the specific focus on 'Internal Control Report' (内部統制報告書) which is a formal assessment of controls, and lacking a specific 'Internal Control Report' code, 'AR' (Audit Report / Information) is the most appropriate classification among the choices, as it covers reports on internal/regulatory stress tests and applied accounting principles/results, which aligns with the nature of an internal control assessment report.
2025-06-24 Japanese
有価証券報告書－第80期(2024/04/01－2025/03/31)
Annual Report Classification · 1% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a header specifying the fiscal year (April 1, 2024, to March 31, 2025), the filing date (June 24, 2025), and extensive XBRL-like metadata tags typical of official annual financial filings submitted to the Kanto Local Finance Bureau. FY 2025
2025-06-24 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.